Generated by AI
AbbVie Inc. is a global biopharmaceutical company that develops, manufactures, and commercializes medicines and therapies for complex and serious diseases. AbbVie focuses on major therapeutic areas including immunology, oncology, neuroscience, eye care, aesthetics, and virology, serving patients with chronic autoimmune conditions, blood cancers, inflammatory disorders, and other specialized medical needs. The company’s portfolio includes branded prescription medicines and advanced therapies distributed through physicians, wholesalers, specialty pharmacies, healthcare facilities, and other healthcare channels. AbbVie also supports contract manufacturing services for selected biologics and pharmaceutical processes. Headquartered in North Chicago, Illinois, AbbVie operates as a research-driven healthcare business with a broad international footprint and a strong role in specialty medicine markets.
Website1 North Waukegan Road
North Chicago, IL, 60064-6400
United States
The latest articles about ABBV.
Detailed price information for Abbvie Inc (ABBV-N) from The Globe and Mail including charting and trades.
Detailed price information for Abbvie Inc (ABBV-N) from The Globe and Mail including charting and trades.
Summary of Nov 17's posts. Generated by AI.
Summary of Nov 17's posts. Generated by AI.
Summary of Mar 18's posts. Generated by AI.
Summary of Nov 17's posts. Generated by AI.
Investors talking about ABBV also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.